Suffolk Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$10.8M Buy
+168,718
New +$12.5M 2.08% 11
2018
Q3
Sell
-162,303
Closed -$12.9M 154
2018
Q2
$12.9M Buy
162,303
+127,156
+362% +$10.6M 1.84% 19
2018
Q1
$3.13M Sell
35,147
-98,991
-74% -$9.5M 0.44% 56
2017
Q4
$14M Buy
134,138
+98,134
+273% +$11.1M 1.82% 18
2017
Q3
$5.25M Sell
36,004
-14,074
-28% -$1.92M 0.69% 50
2017
Q2
$6.5M Sell
50,078
-51,677
-51% -$6.33M 0.86% 50
2017
Q1
$12.7M Buy
101,755
+39,620
+64% +$4.74M 1.69% 27
2016
Q4
$7.19M Buy
62,135
+20,563
+49% +$2.29M 0.98% 43
2016
Q3
$4.35M Sell
41,572
-6,026
-13% -$652K 0.6% 58
2016
Q2
$4.7M Sell
47,598
-18,029
-27% -$1.86M 0.6% 54
2016
Q1
$6.57M Sell
65,627
-32,231
-33% -$3.32M 0.87% 41
2015
Q4
$11.7M Buy
97,858
+31,985
+49% +$3.7M 1.49% 25
2015
Q3
$7.13M Sell
65,873
-5,113
-7% -$635K 0.95% 38
2015
Q2
$8.22M Buy
70,986
+14,314
+25% +$1.64M 0.98% 39
2015
Q1
$6.53M Sell
56,672
-77,342
-58% -$9.24M 0.77% 50
2014
Q4
$15M Sell
134,014
-1,386
-1% -$146K 1.82% 8
2014
Q3
$12.8M Sell
135,400
-21,388
-14% -$1.93M 1.6% 13
2014
Q2
$13.5M Sell
156,788
-18,692
-11% -$1.42M 1.63% 10
2014
Q1
$12.2M Buy
175,480
+36,360
+26% +$2.88M 1.52% 22
2013
Q4
$11.8M Sell
139,120
-17,460
-11% -$1.38M 1.47% 20
2013
Q3
$12.1M Sell
156,580
-2,920
-2% -$205K 1.62% 8
2013
Q2
$9.33M Buy
+159,500
New +$9.6M 1.34% 30

Other funds holding CELG

Suffolk Capital Management's CELG Position: Q4 2018 in Review

Suffolk Capital Management opened a new position in Celgene Corp (CELG) in Q4 2018: 168,718 shares worth $10.8M. The stake represents 2.08% of the portfolio and ranks #11 among its holdings. This is a return to the name: Suffolk Capital Management previously reported a position in CELG as recently as Q2 2018.

Suffolk Capital Management first reported a position in CELG in Q2 2013 and has held it in 22 quarters since. The position peaked at $15M in Q4 2014. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Suffolk Capital Management held 168,718 shares of Celgene Corp worth $10.8M as of Q4 2018.
  • Celgene Corp was a new Suffolk Capital Management position in Q4 2018.
  • Celgene Corp made up 2.08% of Suffolk Capital Management's portfolio in Q4 2018, its #11 holding.
  • Suffolk Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 22 quarters since.
  • Suffolk Capital Management's Celgene Corp position peaked at $15M in Q4 2014.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Suffolk Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.